Table 1 Demographic and clinical-pathologic characteristics of study cohorts
From: A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort
Bladder cancer (n = 211) | control (n = 67) | |
|---|---|---|
Median age (range, years) | 75 (22–95) | 70 (30–90) |
Male:female ratio | 183/28 | 53/14 |
Stage | n/a | |
NMIBC | 170 (80.6 %) | |
MIBC | 41 (19.4 %) | |
Grade | n/a | |
Low | 87 (41.2 %) | |
High | 124 (58.8 %) | |
Clinical stage | n/a | |
Tis high-grade | 7 (3.3 %) | |
Ta low-grade | 80 (37.9 %) | |
Ta high-grade | 29 (13.7 %) | |
T1 low-grade | 7 (3.3 %) | |
T1 high-grade | 47 (22.3 %) | |
≥T2 high-grade | 41 (19.4 %) |